Diabetes Virus Detection Project, Intervention With GAD-alum

NCT01129232 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Complications to procedure

Conditions

Diabetes, Type I
Enterovirus Infections
Autoimmunity

Interventions

DRUG: GAD-alum
OTHER: Placebo

Sponsor

Oslo University Hospital